A selective p38α/β MAPK inhibitor alleviates neuropathology and cognitive impairment, and modulates microglia function in 5XFAD mouse

Abstract Background Chronic neuroinflammation, aggressive amyloid beta (Aβ) deposition, neuronal cell loss, and cognitive impairment are pathological presentations of Alzheimer’s disease (AD). Therefore, resolution of neuroinflammation and inhibition of Aβ-driven pathology have been suggested to be...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Min Sung Gee, Seung Hwan Son, Seung Ho Jeon, Jimin Do, Namkwon Kim, Yeon-Joo Ju, Soo Jin Lee, Eun Kyoung Chung, Kyung-Soo Inn, Nam-Jung Kim, Jong Kil Lee
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	BMC 2020-04-01
Schriftenreihe:	Alzheimer’s Research & Therapy
Schlagworte:	Alzheimer’s disease Amyloid-β P38 mitogen-activated protein kinase Kinase inhibitor Microglia
Online-Zugang:	http://link.springer.com/article/10.1186/s13195-020-00617-2
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!